Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.86 +0.04 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

Lexicon Pharmaceuticals (LXRX) Net Margin (2009 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) recorded Net Margin of -4591.76% in Q2 2026, down 4603.03 percentage points from 11.27% a year earlier and down 4586.82 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Net Margin (2009 - 2026) Analysis & Trends

On a TTM basis, Lexicon Pharmaceuticals' Net Margin came in at -147.38% as of Jun 30, 2026, up 59.05 percentage points year-over-year; for FY2025, it was -101.08%, up 543.70 percentage points from FY2024.

  • Annual Net Margin has increased for three straight years, with a five-year change of +143.03 percentage points (FY2020 to FY2025).
  • Across earlier years, Net Margin came in at -644.78% in FY2024 (+14066.10 pp), -14710.88% in FY2023 (+58630.13 pp), -73341.01% in FY2022 (-43892.01 pp) and -29448.99% in FY2021 (-29204.88 pp).
  • The Q2 2026 figure is the lowest quarterly Net Margin since Q4 2023.
  • On a year-over-year basis, Net Margin rose in six of the last eight quarters, with an average year-over-year change of +5104.19 percentage points.
  • Peak year-over-year performance for Net Margin in the last five years was a gain of 128775.41 percentage points in Q1 2024, against a drop of 180174.41 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -4.94% (Q1 2026), -282.72% (Q4 2025) and -90.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Lexicon Pharmaceuticals 831.26 Mn 190.55 Mn 11.17 Mn -124.49%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -124.49%
Jun 30, 2026 -4,591.76%
Mar 31, 2026 -4.94%
Dec 31, 2025 -282.72%
Sep 30, 2025 -90.04%
Jun 30, 2025 11.27%
Mar 31, 2025 -2,004.36%
Dec 31, 2024 -127.16%
Sep 30, 2024 -3,703.49%
Jun 30, 2024 -3,244.02%
Mar 31, 2024 -4,282.92%
Dec 31, 2023 -7,087.75%
Sep 30, 2023 -31,188.27%
Jun 30, 2023 -14,165.30%
Mar 31, 2023 -133,058.33%
Dec 31, 2022 -108,907.14%
Sep 30, 2022 -59,966.67%
Jun 30, 2022 -70,248.57%
Dec 31, 2021 -182,935.71%
Sep 30, 2021 -100,530.43%
API Access

Lexicon Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=LXRX&period=max&api_key=YOUR_API_KEY